Opiate analgesia and calcium channels modulation by dihydropyridines under acute and tolerant conditions.
Flórez
J
J
Department of Physiology and Pharmacology, University of Cantabria Medical School, Santander, Spain.
Dierssen
M
M
Hurlé
M A
MA
D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / Q000494:pharmacology; D000698:Analgesia; D000818:Animals; D015220:Calcium Channels / Q000187:drug effects*; D004095:Dihydropyridines / Q000494:pharmacology*; D004361:Drug Tolerance; D005283:Fentanyl / Q000031:analogs & derivatives* / Q000097:blood / Q000494:pharmacology; D008297:Male; D009553:Nimodipine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011957:Receptors, Opioid / Q000187:drug effects / Q000502:physiology; D017450:Receptors, Opioid, mu; D017409:Sufentanil
D015220:Calcium Channels; D004095:Dihydropyridines; D011957:Receptors, Opioid; D017450:Receptors, Opioid, mu; D009553:Nimodipine; D001498:3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; D017409:Sufentanil; D005283:Fentanyl